[TARS] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -7.03%
YoY- -220.40%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 13,076 10,000 338 0 0 -
PBT -41,902 -13,599 -14,797 -11,467 -1,412 133.26%
Tax 30,398 -521 54 -1 328 210.03%
NP -41,902 -13,078 -14,851 -11,467 -1,412 133.26%
Tax Rate - - - - - -
Total Cost 54,978 23,078 15,189 11,467 1,412 149.64%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -320.45 -130.78 -4,393.79 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.31 -0.49 -0.72 -0.56 -0.13 78.09%
EPS Diluted -1.31 -0.49 -0.72 -0.53 -0.13 78.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.